The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms
Mild Traumatic Brain Injury, Concussion, Brain
About this trial
This is an interventional treatment trial for Mild Traumatic Brain Injury focused on measuring Concussion, Mild traumatic brain injury, Creatine monohydrate, Persistent post-concussive symptoms
Eligibility Criteria
Inclusion Criteria:
- Have had PPCS for a minimum of six months and a maximum of 12 months at the start of the study.
- Being between 25 and 35 years of age
Exclusion Criteria:
- Elite athletes, as well as people who in general is physical active for more than ten hours a week on average.
- Participation in other interventions/treatment than this study
- Have had PPCS in:
- <6 months
- >12 months
- Pregnant
- Other brain diseases or traumatic injuries
- Musculoskeletal diseases
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
No Intervention
Placebo Comparator
Intervention group
Control group
Placebo
Creatine monohydrate administered once a day for seven weeks - with 5 g/day for the entire period.
The control group will receive standard care. However, to our knowledge there is no common accepted description of a standard care in the literature. In general, these participants will be advised to keep themselves as asymptomatic as possible throughout the entire seven weeks, and besides that live as normal a life as they can.
Powdered Sugar administered once a day for seven weeks - with 5g/day for the entire period.